Pediococcus Acidilactici Postbiotics for Stable Obesity Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing or treating obesity, such as low-calorie diets, exercise, and pharmaceuticals, are challenging to implement and have limited effectiveness due to adaptive physiological mechanisms, while existing probiotics and prebiotics have stability and efficacy issues, and bariatric surgery is not accessible to many.
Innovation Solution
A postbiotic preparation of Pediococcus acidilactici, comprising inanimate bacteria or their components, is used to prevent weight gain and improve obesity-related parameters by reducing adipocyte size, food efficiency, and steatosis, and is stable during industrial processes and safe for consumption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If probiotics (live microorganisms) are used to prevent or treat obesity, then they may provide health benefits, but they have limited shelf-life and are hard to manage in industrial settings
Solution Approach 1:
The patent extracts the beneficial metabolic functions of live bacteria by using postbiotic preparations containing bacterial metabolites, cell wall components, and other biochemical substances. This extraction allows the health benefits to be preserved while eliminating the limitations of live microorganisms regarding shelf-life and industrial management.
Solution Approach 2:
The patent changes the state parameter of the bacterial preparation from live to inactivated/postbiotic form. This parameter change maintains the bioactive components responsible for health benefits while removing the viability requirement, thereby extending shelf-life and improving industrial manageability without sacrificing therapeutic efficacy.
2Ease of manufacture
If prebiotics are used to prevent or treat obesity, then they serve as substrates for gut microbiota, but they have limited efficacy by themselves
Solution Approach 1:
The patent creates a composite postbiotic preparation that combines multiple bacterial metabolites, cell wall components, and other biochemical substances from Pediococcus acidilactici. This composite approach synergistically combines different bioactive components to achieve superior obesity treatment efficacy compared to single prebiotic substances, while maintaining the stability advantages of non-living materials.
3Reliability
If pharmaceuticals like GLP-1 analogues are used for obesity treatment, then they can achieve weight reduction, but they have side effects including gastrointestinal disorders and are expensive
Solution Approach 1:
The patent employs postbiotic preparations that are stable, non-living substances derived from bacteria. These preparations offer a more affordable and accessible alternative to expensive pharmaceuticals like GLP-1 analogues, while providing sustained efficacy through their stability. The approach eliminates the need for continuous expensive medication by using stable postbiotic components that can be incorporated into food or supplement products.
4Reliability
If bariatric surgery is performed for obesity treatment, then significant weight reduction is achieved, but it is neither accessible nor suitable for many individuals
Solution Approach 1:
The patent develops postbiotic preparations that can be self-administered through oral intake as food supplements or functional foods. This self-service approach eliminates the need for complex surgical procedures, making obesity treatment accessible to a much broader population without requiring medical intervention, hospitalization, or specialized surgical expertise.
Data Source
Figure 1~3
Figure 4~6
Figure 7~9B
AI summary
The present invention refers to a postbiotic preparation of Pediococcus acidilactici (P. acidilactici), for use in preventing and/or treating obesity and overweight, in reducing body fat, in preventing fat accumulation, in reducing appetite, in reducing food intake, or in preventing weight gain. The preparation may further comprise zinc, chromium or active ingredients effective in preventing and/or treating obesity, in reducing body fat, in preventing fat accumulation, in reducing appetite, in reducing food intake, in preventing adipogenesis in the adipose tissue, or in preventing weight gain